| Particulars |
|
|
|
| Company Name
| Sanofi India Ltd
| Year End
| 202412
|
| Full Year |
| Equity (₹ Cr.) |
23.03 |
B.V. (₹) |
373.70 |
| Sales(₹ Cr.) |
2,013.20 |
NP (₹ Cr.) |
442.27 |
| NP Var% |
-25.00 |
Div% |
1,170.00 |
| CPS(₹) |
208.00 |
EPS (₹) |
192.00 |
| Traded Value(₹ Lakhs) |
25.04 |
52 Week High |
7,594.00 |
| 52 Week Low |
4,146.00 |
Price BSE |
6,087.00 |
| Price NSE |
6,081.00 |
Market Capital (₹ Cr.) |
14,018.02 |
| P/C Ratio |
29.30 |
P/E Ratio |
31.70 |
| Price Vs.BV |
16.29 |
|
| Latest Quarter |
| Year End |
202503 |
Sales (₹ Cr.) |
535.90 |
| NP(₹ Cr.) |
119.50 |
NP Var % |
10.00 |
| Trailing Twelve Months |
| Year End |
202503 |
Sales |
2,192.20 |
| OPM |
22.35 |
NP |
421.55 |
| NP Var% |
11.67 |
EPS |
164.93 |
| PE |
36.91 |
|
|